Erik Harris

Erik Harris

Director/Board Member at DENALI THERAPEUTICS INC.

Net worth: 3 M $ as of 2024-03-30

54 year
Health Technology
Consumer Services
Commercial Services

Profile

Erik C.
Harris
is currently an Independent Director at Denali Therapeutics, Inc. and a Trustee at East Bay Zoological Society.
He previously held positions as the Chief Commercial Officer & Executive VP at Ultragenyx Pharmaceutical, Inc. and as a Senior Director-Marketing & Sales at Elan Corp.
Plc.
He also served as the Manager-Sales & Marketing at Bristol Myers Squibb Co., the Head-Sales & Marketing at Genentech, Inc., the Vice President-Pulmonology Marketing at InterMune, Inc., and the Vice President-Marketing & Sales at Crescendo Bioscience LLC.
Mr. Harris received his undergraduate degree from the United States Naval Academy and his MBA from The Wharton School of the University of Pennsylvania.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2024-02-29 67,163 ( 0.08% ) 3 M $ 2024-03-30
2023-05-31 11,085 ( 0.01% ) 227 464 $ 2024-03-30

Erik Harris active positions

CompaniesPositionStart
ULTRAGENYX PHARMACEUTICAL INC. Corporate Officer/Principal 2016-12-31
DENALI THERAPEUTICS INC. Director/Board Member 2022-02-06
Director/Board Member -
All active positions of Erik Harris

Former positions of Erik Harris

CompaniesPositionEnd
Sales & Marketing 2017-05-31
INTERMUNE INC Sales & Marketing 2010-07-31
Corporate Officer/Principal 2006-12-31
BRISTOL-MYERS SQUIBB COMPANY Sales & Marketing 2000-12-31
Sales & Marketing -
See the detail of Erik Harris's experience

Training of Erik Harris

United States Naval Academy Undergraduate Degree
The Wharton School of the University of Pennsylvania Masters Business Admin

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Erik Harris's experience

Connections

99

1st degree connections

10

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies3
BRISTOL-MYERS SQUIBB COMPANY

Health Technology

ULTRAGENYX PHARMACEUTICAL INC.

Health Technology

DENALI THERAPEUTICS INC.

Health Technology

Private companies5

Health Technology

Health Technology

Health Technology

Commercial Services

Consumer Services

See company connections